Description

InPen is an FDA-cleared smart insulin pen that connects with the InPen mobile app via Bluetooth®.

  • Battery lasts a full year - no charging needed
  • Delivers precise half-unit doses
  • Monitors insulin temperature
  • Compatible with Novolog®, Humalog®, and Fiasp® insulin cartridges (sold separately)
  • Can be used with the Instinct sensor, made by Abbott, or the Simplera™ sensor
  • Integrates with the MiniMed Go™ system for a fully connected diabetes management experience
  • Indicated for all ages. Under age 7 with adult supervision only
  • MiniMed Go™ app available for no cost download on Apple®App Store and Google Play Store. Use the InPen app with a standalone smart pen, or the MiniMed Go™ app if using the MiniMed Go™ system.
  • Looking for the MiniMed Go™ system? Explore it here.


Important Safety Information

Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.

InPen is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient-specific criteria and targets. InPen requires a prescription. For additional product and safety information, please consult the Instructions for Use and InPen Safety. For additional product and safety information, please consult the user guide.


MiniMed Go System (InPen + Instinct+ Simplera)

The MiniMed Go system includes the MiniMed Go app, InPen smart insulin pen injector and either the Instinct continuous glucose monitoring (CGM) sensor or Simplera CGM sensor. The system is intended to aid in diabetes management through multiple daily injections of compatible rapid-acting insulins (Humalog, Novolog, or Fiasp). The app and system components each require a prescription. When used with Instinct CGM, the app is indicated for patients ages 7 years and older, or patients ages 2 to 6 years under the supervision of an adult caregiver. When used with Simplera CGM, the app is indicated for patients ages 18 and over. If using InPen alone, the app is intended for all ages, with patients under age 7 requiring supervision. Use of these systems requires, among other things, adequate hearing and vision, a compatible mobile device and operating system, an open app, adequate pairing and connectivity, proper setting, use of an approved rapid-acting insulin, mobile device battery power, proper settings, accurate manual logging of insulin doses administered by means other than InPen, and occasional blood glucose meter (BGM) readings. Establishment of settings and treatment decisions should be made in consultation with a healthcare professional and on the basis of a combination of glucose readings, trend arrows, glucose target, active alerts, and recent events (such as insulin doses, exercise, meals, and medications). Failure to observe these and other details as found in the user guides can result in incorrect dosing, missed alerts and notifications, and ultimately hypoglycemia or hyperglycemia, with serious injury or death possible. For additional safety information and user guides, see MiniMedRisks.

InPen Smart Insulin Pen, Pink

Product code: MMT-105NNPKNA

Price varies

pending insurance

Covered by most insurance

Rx icon Prescription required

Select insulin cartridge type

*Insulin cartridges sold separately

Color

Description

InPen is an FDA-cleared smart insulin pen that connects with the InPen mobile app via Bluetooth®.

  • Battery lasts a full year - no charging needed
  • Delivers precise half-unit doses
  • Monitors insulin temperature
  • Compatible with Novolog®, Humalog®, and Fiasp® insulin cartridges (sold separately)
  • Can be used with the Instinct sensor, made by Abbott, or the Simplera™ sensor
  • Integrates with the MiniMed Go™ system for a fully connected diabetes management experience
  • Indicated for all ages. Under age 7 with adult supervision only
  • MiniMed Go™ app available for no cost download on Apple®App Store and Google Play Store. Use the InPen app with a standalone smart pen, or the MiniMed Go™ app if using the MiniMed Go™ system.
  • Looking for the MiniMed Go™ system? Explore it here.


Important Safety Information

Smart insulin pens connect to a mobile app to provide dosing calculations, reminders and CGM system integration.

InPen is a home-use reusable pen injector for single-patient use by people with diabetes under the supervision of an adult caregiver, or by a patient age 7 and older for the self-injection of a desired dose of insulin and for calculating an insulin dose or carbohydrate intake based on user entered data. A healthcare professional must assist in dosage programming of the device prior to use, based on various patient-specific criteria and targets. InPen requires a prescription. For additional product and safety information, please consult the Instructions for Use and InPen Safety. For additional product and safety information, please consult the user guide.


MiniMed Go System (InPen + Instinct+ Simplera)

The MiniMed Go system includes the MiniMed Go app, InPen smart insulin pen injector and either the Instinct continuous glucose monitoring (CGM) sensor or Simplera CGM sensor. The system is intended to aid in diabetes management through multiple daily injections of compatible rapid-acting insulins (Humalog, Novolog, or Fiasp). The app and system components each require a prescription. When used with Instinct CGM, the app is indicated for patients ages 7 years and older, or patients ages 2 to 6 years under the supervision of an adult caregiver. When used with Simplera CGM, the app is indicated for patients ages 18 and over. If using InPen alone, the app is intended for all ages, with patients under age 7 requiring supervision. Use of these systems requires, among other things, adequate hearing and vision, a compatible mobile device and operating system, an open app, adequate pairing and connectivity, proper setting, use of an approved rapid-acting insulin, mobile device battery power, proper settings, accurate manual logging of insulin doses administered by means other than InPen, and occasional blood glucose meter (BGM) readings. Establishment of settings and treatment decisions should be made in consultation with a healthcare professional and on the basis of a combination of glucose readings, trend arrows, glucose target, active alerts, and recent events (such as insulin doses, exercise, meals, and medications). Failure to observe these and other details as found in the user guides can result in incorrect dosing, missed alerts and notifications, and ultimately hypoglycemia or hyperglycemia, with serious injury or death possible. For additional safety information and user guides, see MiniMedRisks.